Concepedia
Statistics
Publications
3
Citations
172
H-Index
Active since
2013
Affiliations
University of Bern(Current)
University Hospital of Bern
Merck KGaA, Darmstadt (Germany)
Kei Mikami is an author at University of Bern specializing in molecular oncology, medicine, and met inhibitors.
Publications per year
2013–2015
Antitumor Effect of SIRT1 Inhibition in Human HCC Tumor Models <i>In Vitro</i> and <i>In Vivo</i>
Simone Portmann, René Fahrner, Antje Lechleiter et al. · Molecular Cancer Therapeutics · 2013 · 113 citations
Medicine, Cancer Biology, Molecular Biology +16
Impact of p53 Status on Radiosensitization of Tumor Cells by MET Inhibition–Associated Checkpoint Abrogation
Kei Mikami, Michaela Medová, Lluís Nisa et al. · Molecular Cancer Research · 2015 · 32 citations
Medicine, Oncology, Radiation Oncology +17
KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET‐expressing tumor cells
Dominic Leiser, Michaela Medová, Kei Mikami et al. · Molecular Oncology · 2015 · 27 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–3 of 3